Free Trial

Promising Medical Stocks To Follow Today - May 6th

UnitedHealth Group logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • MarketBeat's stock screener identifies the top medical stocks to watch today as UnitedHealth Group (UNH), Cencora (COR), and McKesson (MCK) because they recorded the highest dollar trading volume among medical stocks in recent days.
  • UnitedHealth Group is a diversified U.S. healthcare company operating through UnitedHealthcare and three Optum segments that provide health plans, care services, analytics, and pharmacy solutions.
  • Cencora and McKesson are leading pharmaceutical distributors and services providers—Cencora focuses on sourcing, distribution, pharmacy management, and commercialization support, while McKesson distributes pharmaceuticals and offers prescription technology and medical-surgical solutions.
  • Interested in UnitedHealth Group? Here are five stocks we like better.

UnitedHealth Group, Cencora, and McKesson are the three Medical stocks to watch today, according to MarketBeat's stock screener tool. "Medical stocks" are publicly traded shares of companies that operate in the healthcare and medical industries, including pharmaceuticals, biotechnology, medical device manufacturers, diagnostics, and healthcare providers. Investors typically treat them as a way to gain exposure to drug development, medical technology and healthcare services, while weighing sector-specific factors such as regulatory approval, clinical trial outcomes, patent protection and reimbursement policies. These companies had the highest dollar trading volume of any Medical stocks within the last several days.

UnitedHealth Group (UNH)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Read Our Latest Research Report on UNH

Cencora (COR)

Cencora, Inc. sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers.

Read Our Latest Research Report on COR

McKesson (MCK)

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.

Read Our Latest Research Report on MCK

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Hottest IPOs On Wall Street’s 2026 Watchlist Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines